|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-10-7
|
|
pubmed:abstractText |
A phase I study of weekly intravenous paclitaxel combined with a fixed dose of S-1, a dihydropyrimidine-dehydrogenase-inhibitory oral fluoropyrimidine, was conducted for patients with advanced or recurrent gastric cancer (ARGC). Endpoints of this study were to examine the toxicity profile OF this regimen and to determine the recommended dose (rd) of paclitaxel.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0030-2414
|
|
pubmed:author |
pubmed-author:IchikawaDaisukeD,
pubmed-author:KakiharaNaokiN,
pubmed-author:KoizumiKinyaK,
pubmed-author:KuriokaHideakiH,
pubmed-author:MoriiJunJ,
pubmed-author:MoritaSatoshiS,
pubmed-author:NakamuraKanaeK,
pubmed-author:NishiyamaMasahikoM,
pubmed-author:SakamotoJunichiJ,
pubmed-author:ShimotsumaMasatakaM,
pubmed-author:TakenakaAtsushiA,
pubmed-author:UedaYujiY,
pubmed-author:YamagishiHisakazuH,
pubmed-author:YamashitaTetsuroT
|
|
pubmed:copyrightInfo |
Copyright (c) 2005 S. Karger AG, Basel.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
69
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
261-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16138002-Adult,
pubmed-meshheading:16138002-Aged,
pubmed-meshheading:16138002-Antimetabolites, Antineoplastic,
pubmed-meshheading:16138002-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:16138002-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16138002-Drug Administration Schedule,
pubmed-meshheading:16138002-Drug Combinations,
pubmed-meshheading:16138002-Feasibility Studies,
pubmed-meshheading:16138002-Female,
pubmed-meshheading:16138002-Humans,
pubmed-meshheading:16138002-Male,
pubmed-meshheading:16138002-Middle Aged,
pubmed-meshheading:16138002-Neoplasm Recurrence, Local,
pubmed-meshheading:16138002-Oxonic Acid,
pubmed-meshheading:16138002-Paclitaxel,
pubmed-meshheading:16138002-Pyridines,
pubmed-meshheading:16138002-Stomach Neoplasms,
pubmed-meshheading:16138002-Tegafur,
pubmed-meshheading:16138002-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Phase I study of a combination of s-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.
|
|
pubmed:affiliation |
Department of Surgery, Division of Digestive Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan. yueda@koto.kpu-m.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
